Early coronavirus drug trials tested vaccines mostly on White people; next phase aims for diversity
July 31, 2020 at 10:40 AM EDT
The first large-scale efficacy trials of potential Covid-19 vaccines began Monday in the U.S. A key priority is recruiting participants of diverse backgrounds. It may be a challenge.
